Inlyta Cost, Coupons and Savings

Inlyta cost with Medicare in 2026

In 2026, Part D plans can charge a deductible of up to $615, and once your out-of-pocket spending on covered Part D drugs reaches $2,100, you pay nothing more for covered drugs for the rest of the year. What you pay for Inlyta depends on your plan's drug list. If your income is limited, Extra Help and Pfizer's patient assistance program may lower your cost.

Inlyta coupons and savings programs

eDrugSearch does not offer its own Inlyta coupons. These programs can help with the cost of Inlyta:

• Pfizer Oncology Together Co-Pay Savings Program: for people with commercial insurance, such as a plan through work. Eligible patients may pay as little as $0 a month for Inlyta, and the program covers up to $10,000 per product each year. Limits, terms and conditions apply. Because it's for commercial insurance only, it can't be used with Medicare or Medicaid. (Inlyta.com)
• Pfizer Patient Assistance Program: free Inlyta from Pfizer for people who are uninsured or covered by a government plan, can't afford their out-of-pocket costs, and have household income at or below 300% of the federal poverty level. People with Medicare must also join the Medicare Prescription Payment Plan. People with commercial insurance can't use it. Call 1-877-744-5675. (Pfizer enrollment form)
• Medicare Extra Help: if you have Medicare and limited income, Extra Help lowers what you pay for prescriptions. (Social Security)
• Medicare Prescription Payment Plan: a free Medicare option that spreads your drug costs into monthly payments across the year. It doesn't lower the total, but it can make costs easier to manage. (Medicare.gov)

Compare Inlyta with similar drugs

Other targeted cancer pills (kinase inhibitors) people often look up, such as Gleevec and Tasigna. They treat different cancers than Inlyta. Prices are for each drug's lowest-priced strength.

Lowest 90-day price including shipping, from licensed pharmacies shipping to the U.S., any strength. Only your doctor can decide whether another drug is right for you.

What is Inlyta used for?

Inlyta (axitinib) is a kinase inhibitor, a targeted cancer medicine that blocks signals tumors use to grow new blood vessels. According to its FDA label (DailyMed), it is used:

• With avelumab (Bavencio), as a first treatment for advanced kidney cancer (renal cell carcinoma).
• With pembrolizumab (Keytruda), as a first treatment for advanced kidney cancer.
• On its own, for advanced kidney cancer after one earlier treatment stopped working.

Inlyta comes as 1 mg and 5 mg tablets. The label's usual starting dose is 5 mg twice a day, about 12 hours apart, with or without food, swallowed whole with a glass of water. The label lets the prescriber raise or lower the dose based on how well a person tolerates it. Inlyta has no boxed warning. Your prescriber decides which medicine is right for you.

Frequently asked questions